Rao S, Horwitz S B, Ringel I
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, N.Y. 10461.
J Natl Cancer Inst. 1992 May 20;84(10):785-8. doi: 10.1093/jnci/84.10.785.
Taxol is a potent inhibitor of the replication of eukaryotic cells and has significant antitumor activity in human malignancies. The drug induces the formation of bundles of stable microtubules and blocks cells in the mitotic phase of the cell cycle. In vitro, taxol enhances the polymerization of tubulin to microtubules that are resistant to depolymerization. Although it is evident that taxol interacts with the tubulin-microtubule system, no information has been available on the binding site for the drug on the microtubule.
Our purpose was to determine if taxol binds to one or both of the tubulin subunits.
In the absence of a photoaffinity-labeled analogue of taxol, [3H]taxol was used directly to photolabel tubulin. A complex of microtubule protein and [3H]taxol was irradiated by ultraviolet light and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
The radiolabeled drug preferentially binds covalently to the beta-subunit of tubulin, and the binding can be competed with unlabeled taxol.
This observation is the first step in a study to determine the binding site for taxol on the microtubule.
紫杉醇是一种有效的真核细胞复制抑制剂,对人类恶性肿瘤具有显著的抗肿瘤活性。该药物可诱导稳定微管束的形成,并使细胞阻滞于细胞周期的有丝分裂期。在体外,紫杉醇可增强微管蛋白聚合成抗解聚的微管。虽然紫杉醇与微管蛋白 - 微管系统相互作用已很明确,但关于该药物在微管上的结合位点尚无相关信息。
我们的目的是确定紫杉醇是否与微管蛋白的一个或两个亚基结合。
在没有紫杉醇的光亲和标记类似物的情况下,直接使用[³H]紫杉醇对微管蛋白进行光标记。微管蛋白和[³H]紫杉醇的复合物经紫外线照射后,通过十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳进行分析。
放射性标记的药物优先与微管蛋白的β亚基共价结合,且这种结合可被未标记的紫杉醇竞争。
这一观察结果是确定紫杉醇在微管上结合位点研究的第一步。